- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 658
Daily deal net: September 13, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sep 13, 2019Trifacta wrangles $100m
Trifacta, co-founded by Stanford and UC Berkeley researchers, has attracted nearly a dozen investors for a round that brought its total funding to $224m.
Sep 13, 201910x floats in enlarged $390m IPO
The SoftBank-backed biological analysis technology provider priced its shares above its range and will likely close the offering at $449m.
Sep 13, 2019Trifacta wrangles $100m
Telstra, NTT Docomo, BMW, Google, Infosys and ABN Amro were among nearly a dozen investors that helped bring the data sorting platform's overall funding to $224m.
Sep 13, 2019Corporates jolt Volta Charging's series C to $100m
SK E&S, Invenergy and Schneider Electric helpeed add $20m to the latest round for EV charging network Volta Charging, which includes a $44m debt facility.
Sep 13, 2019McRock Capital makes first close for second fund
Limited partners including Cisco Investments and Shell have helped McRock Fund II achieve a $60.9m close, putting it 80% of the way to its target.
Sep 13, 2019Marketing Architects builds corporate venturing unit
The advertising agency has set up Zoomworks Ventures to back marketing and advertising technology startups and has already made its first three investments.
Sep 13, 2019Arkansas celebrates record invention haul
University of Arkansas Technology Ventures pushed forth with 47 invention disclosures in 2018-19, a 52% year-on-year rise.
Sep 13, 2019Dill leaves Statkraft for season at EIP
Energy Impact Ventures has hired Matthias Dill, formerly a managing director at Statkraft Ventures, in a managing partner position.
Sep 13, 2019Anokion knocks up $40m series B
Novartis and Novo helped provide $40m for the autoimmune disease therapy developer that supported its acquisition of joint venture Kanyos Bio.
Sep 12, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


